Patient and Provider Opportunities
The Hepatitis B Foundation is pleased to share information about current and upcoming opportunities for people living with hepatitis B and their providers. These opportunities can be tools and resources, clinical trials, or other research opportunities to learn more from people who have hepatitis B.
Do you or someone you know have Hepatitis D? If so, get in touch – we’d love to hear from you.
Elma Research is conducting a study on the experiences of people with Hepatitis Delta Virus (HDV).
We would like to speak with people with Hepatitis D in the UK and France to discuss their experiences with the disease so we can learn what life is like living with the virus.
The study is an online community, with monthly tasks – this could be anything from introducing yourself, to answering questions on a particular topic or looking at some information and telling us what you think about it. If interested, participants can also interact anonymously with others to discuss defined topics around Hepatitis D. If you can’t get online, don’t worry we still want to hear from you – just get in touch.
You would need 1 hour per month for 3-12 months - we appreciate the time invested and for this reason we offer an incentive of €50 (France)/£55 (UK) per month. Your responses will remain anonymous and be kept confidential. Your feedback will be used by our sponsor on how they can help HDV patients now and in the future.
If you are interested or know someone who might be, please contact us at:
Elma Research organizes market research studies in the medical sector. You can find out more about us at https://www.elmaresearch.com/.
U.S. researchers seeking people living with hepatitis B
Researchers across the U.S. are recruiting people living with hepatitis B for a clinical trial of a potential new treatment, which is called Cemiplimab. Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the study is being led by a University of California at Los Angeles team and has sites in L.A., New York City, Atlanta and other locations. If you’re interested, you can find eligibility information on ClinicalTrials.gov, using the identifier (NCT number): NCT04046107. Enrollment must be done through a physician.
Attention patients with hepatitis B:
Your source for HBV education and tools. View the CME Outfitters HBV Patient Hub here.
CME Outfitters presents a webcast series aimed at helping pharmacists better care for those with hepatitis B.
- Part 1: Screening and Interpreting Hepatitis B Serologic Results to Inform Treatment Decisions
- Part 2: Patients with Hepatitis B: Medical Comorbidities That Can Impact Treatment and Prompt the Provider to Switch
- Part 3: Beyond the Prescription Refill: The Role of the Pharmacist in Ongoing Monitoring of Patients with HBV
CME Outfitters has a wealth of information about treating patients with hepatitis B. This informative webcast is just one opportunity:
Test Your Knowledge: An Interactive Session on Emerging Data and Expert Insights on Hepatitis B. View this webcast here.
Complimentary CME Activity:
Hepatitis B Recognition and Care Determination in Primary Care
In this accredited CME activity, expert faculty discuss:
- Recommendations for hepatitis B virus (HBV) screening and testing
- Best practices for patient education and counseling
- Treatment considerations for patients with chronic HBV
- Hepatocellular carcinoma (HCC) risk, screening, and surveillance
In addition, patient advocates provide perspectives from the patient community on challenges faced regarding HBV screening, testing, and treatment.
Disclaimer – The opportunities listed on this page do not represent all available opportunities. The Hepatitis B Foundation receives funding to provide information about the specific opportunities listed on this page. The Hepatitis B Foundation follows IRB-approved protocols and our own Corporate Ethics Policy for all listings. If you are interested in having an opportunity listed on this page, please email firstname.lastname@example.org.